Clinical Trials Directory

Trials / Unknown

UnknownNCT01587326

The Effects of Escitalopram on Cytokines

The Effects of Escitalopram on Cytokines in Depressive Patients

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
25 (estimated)
Sponsor
Beitou Armed Forces Hospital, Taipei, Taiwan · Other Government
Sex
All
Age
20 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The association of cytokines with escitalopram has not been investigated in patients with major depressive disorder (MDD). Hence, the investigators will examine this association.

Detailed description

In addition to serotonin, inflammatory process has been suggested in the development of major depressive disorder (MDD) and in its associated treatment. Escitalopram is an antidepressant that has been widely used in patients with MDD because of the promising results. The association of cytokines with escitalopram has not been investigated in patients with MDD. Hence, the investigators will examine this association.

Conditions

Interventions

TypeNameDescription
DRUGEscitalopramescitalopram 10 mg/d to 20 mg/d

Timeline

Start date
2012-04-01
Primary completion
2013-04-01
Completion
2013-04-01
First posted
2012-04-30
Last updated
2012-05-15

Locations

1 site across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT01587326. Inclusion in this directory is not an endorsement.